IDERJ - Instituto de Dermatologia e Estética do Brasil

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Alopecia areata1 trial
• Atopic dermatitis (eczema)1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Eli Lilly and Company2 trials

Closed trials

• Completed

  A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

  NCT03899259· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

  NCT03952559· Phase 3· Eli Lilly and Company· Source